Neal James R
SEC-identified person · CIK 1600865 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Processa Pharmaceuticals, Inc. PCSA | Director | filed 2022–2026 |
| Celsus Therapeutics Plc. CLTX | Director | filed 2024–2026 |
| Peak Bio, Inc. PKBO | Director | filed 2022–2024 |
| Seneca Biopharma, Inc. SNCA | Director | filed 2021–2024 |
| Xoma Royalty Corp XOMAD | Director · VP Business Development | filed 2014–2022 |
| Monterey Innovation Acquisition Corp MTRY | Director | filed 2021–2021 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.